PAG
CORV

Private Advisor Group’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Private Advisor Group’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,500
Closed -$33K – 1779
2019
Q3 		$33K Buy
+16,500
New +$33.4K ﹤0.01% 1620

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Private Advisor Group's CORV Position: Q4 2019 in Review

Private Advisor Group sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 16,500 shares — an estimated $33K sold.

Private Advisor Group first reported a position in CORV in Q3 2019 and held it in 1 quarter. The position peaked at $33K in Q3 2019. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

  • Private Advisor Group reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
  • Private Advisor Group sold 16,500 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $33K.
  • Private Advisor Group first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2019 and held it in 1 quarter.
  • Private Advisor Group's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $33K in Q3 2019.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Private Advisor Group's 13F filing for Q4 2019, filed 10 Feb 2020.